STRONG COMPARISON BASE, PANVEL HAS SALES GROWTH OF 9,5% VS 2T22
Retail Gross Revenue
(BRL million)
Average Sales Evolution per Store in the South Region (BRL CPP)
+11,7%
+9,5%
577
598
1,070.3
1,056.7
995.3
1,002.4
1,842.8
2,059.1
965.4
2Q22 3Q22 4Q22 1Q23 2Q23 1H22 1H23
532
322
567
334
Retail Sales Growth
-16,4 p.p.
-10,9 p.p.
26.3%
25.9%
22.6%
21.1%
14.2%
11.7%
9.5%
2Q22 3Q22 4Q22 1Q23 2Q23 1H22 1H23
119
123
62
63
Fonte: IQVIA
2T22
2T23
Panvel
Abrafarma
Chain
Assoc / Franc
Independents
Average sales reach
BRL 614 thousand per store in
2Q23
BRL 598 thousand/store in 2Q22
5
Pública
Attention: This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Dimed SA Distribuidora de Medicamentos published this content on 11 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2023 13:21:26 UTC.
Dimed SA Distribuidora de Medicamentos, formerly Panvel SA Drogarias e Farmacias, is a Brazil-based company principally engaged in the sale of drugs. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. It organizes its business into two main segments: Medicine and Perfumery. The Company provides retail and wholesale distribution. The Company owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.
DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS 
